Acadia Healthcare (NASDAQ:ACHC) Price Target Cut to $76.00 by Analysts at Barclays

Acadia Healthcare (NASDAQ:ACHC) had its target price trimmed by Barclays from $83.00 to $76.00 in a research note published on Monday morning, Benzinga reports. The firm currently has an overweight rating on the stock.

Several other analysts have also issued reports on ACHC. Royal Bank of Canada restated an outperform rating and issued a $94.00 target price on shares of Acadia Healthcare in a research note on Friday, September 20th. Deutsche Bank Aktiengesellschaft increased their target price on Acadia Healthcare from $70.00 to $75.00 and gave the stock a hold rating in a research report on Friday, August 2nd. Finally, Cantor Fitzgerald reissued a neutral rating and issued a $90.00 target price on shares of Acadia Healthcare in a report on Monday, August 19th. One research analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, Acadia Healthcare has an average rating of Moderate Buy and an average price target of $86.67.

Acadia Healthcare Price Performance

Shares of ACHC opened at $56.71 on Monday. The business has a 50-day moving average of $73.97 and a 200-day moving average of $71.31. Acadia Healthcare has a 1 year low of $53.22 and a 1 year high of $87.77. The company has a market capitalization of $5.26 billion, a price-to-earnings ratio of -405.79, a price-to-earnings-growth ratio of 2.19 and a beta of 1.30. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.18 and a quick ratio of 1.18.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, July 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.87 by $0.04. The company had revenue of $796.00 million during the quarter, compared to the consensus estimate of $784.38 million. Acadia Healthcare had a positive return on equity of 11.42% and a negative net margin of 0.17%. The firm’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.92 EPS. As a group, equities research analysts anticipate that Acadia Healthcare will post 3.51 earnings per share for the current year.

Institutional Investors Weigh In On Acadia Healthcare

A number of large investors have recently modified their holdings of ACHC. Blue Trust Inc. lifted its holdings in Acadia Healthcare by 86.1% in the second quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after acquiring an additional 248 shares during the period. Mather Group LLC. acquired a new position in shares of Acadia Healthcare during the first quarter valued at $48,000. Point72 Asia Singapore Pte. Ltd. bought a new position in Acadia Healthcare during the second quarter valued at about $59,000. nVerses Capital LLC acquired a new position in shares of Acadia Healthcare in the 2nd quarter valued at $95,000. Finally, Innealta Capital LLC purchased a new stake in shares of Acadia Healthcare during the 2nd quarter worth about $164,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.